| GSK |
206867 |
A Phase 3, 24-week, randomized, double-blind, parallel-group Bayesian Dynamic Borrowing study comparing the efficacy, safety, tolerability and pharmacokinetics of FF/UMEC/VI with FF/VI in 12-17-year-old participants with inadequately controlled asthma on stable maintenance therapy with ICS/LABA |
CANSIN SAÇKESEN (Prof.Dr.) |
Phase 3 |
Pediatric Allergy and Immunologic Diseases |
Asthma Disease |